326 related articles for article (PubMed ID: 27083518)
1. Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection.
Iguchi M; Kato J; Yoshida T; Yamamoto Y; Nakachi K; Fukatsu K; Mori Y; Maeda Y; Moribata K; Shingaki N; Niwa T; Deguchi H; Inoue I; Maekita T; Tamai H; Ichinose M
Int J Cancer; 2016 Sep; 139(5):1150-6. PubMed ID: 27083518
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
Kwon Y; Jeon S; Nam S; Shin I
Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258
[TBL] [Abstract][Full Text] [Related]
3. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.
Mori G; Nakajima T; Asada K; Shimazu T; Yamamichi N; Maekita T; Yokoi C; Fujishiro M; Gotoda T; Ichinose M; Ushijima T; Oda I
Gastric Cancer; 2016 Jul; 19(3):911-8. PubMed ID: 26420267
[TBL] [Abstract][Full Text] [Related]
4. Association between
Kim SB; Lee SH; Bae SI; Jeong YH; Sohn SH; Kim KO; Jang BI; Kim TN
World J Gastroenterol; 2016 Nov; 22(44):9794-9802. PubMed ID: 27956803
[TBL] [Abstract][Full Text] [Related]
5. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
Yanaoka K; Oka M; Ohata H; Yoshimura N; Deguchi H; Mukoubayashi C; Enomoto S; Inoue I; Iguchi M; Maekita T; Ueda K; Utsunomiya H; Tamai H; Fujishiro M; Iwane M; Takeshita T; Mohara O; Ichinose M
Int J Cancer; 2009 Dec; 125(11):2697-703. PubMed ID: 19610064
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.
Maehata Y; Nakamura S; Fujisawa K; Esaki M; Moriyama T; Asano K; Fuyuno Y; Yamaguchi K; Egashira I; Kim H; Kanda M; Hirahashi M; Matsumoto T
Gastrointest Endosc; 2012 Jan; 75(1):39-46. PubMed ID: 22018552
[TBL] [Abstract][Full Text] [Related]
7. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
8. Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.
Boda T; Ito M; Yoshihara M; Kitamura Y; Matsuo T; Oka S; Tanaka S; Chayama K
Helicobacter; 2014 Feb; 19(1):1-8. PubMed ID: 24215601
[TBL] [Abstract][Full Text] [Related]
9. Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial.
Choi JM; Kim SG; Choi J; Park JY; Oh S; Yang HJ; Lim JH; Im JP; Kim JS; Jung HC
Gastrointest Endosc; 2018 Sep; 88(3):475-485.e2. PubMed ID: 29800546
[TBL] [Abstract][Full Text] [Related]
10. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
[TBL] [Abstract][Full Text] [Related]
11. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
12. The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer.
Kim YI; Choi IJ; Kook MC; Cho SJ; Lee JY; Kim CG; Ryu KW; Kim YW
Helicobacter; 2014 Jun; 19(3):194-201. PubMed ID: 24612125
[TBL] [Abstract][Full Text] [Related]
13. Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm.
Bae SE; Jung HY; Kang J; Park YS; Baek S; Jung JH; Choi JY; Kim MY; Ahn JY; Choi KS; Kim DH; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Am J Gastroenterol; 2014 Jan; 109(1):60-7. PubMed ID: 24343545
[TBL] [Abstract][Full Text] [Related]
14. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication.
Shiotani A; Uedo N; Iishi H; Yoshiyuki Y; Ishii M; Manabe N; Kamada T; Kusunoki H; Hata J; Haruma K
Digestion; 2008; 78(2-3):113-9. PubMed ID: 19023205
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of pepsinogen I/II ratio after eradication of Helicobacter pylori in patients who underwent endoscopic mucosal resection for gastric cancer.
Nam SY; Jeon SW; Lee HS; Kwon YH; Park H; Choi JW
Dig Liver Dis; 2017 May; 49(5):500-506. PubMed ID: 28057446
[TBL] [Abstract][Full Text] [Related]
17. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
Watanabe M; Kato J; Inoue I; Yoshimura N; Yoshida T; Mukoubayashi C; Deguchi H; Enomoto S; Ueda K; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Tekeshita T; Mohara O; Ushijima T; Ichinose M
Int J Cancer; 2012 Dec; 131(11):2632-42. PubMed ID: 22383377
[TBL] [Abstract][Full Text] [Related]
18. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
[TBL] [Abstract][Full Text] [Related]
19. Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication.
Okada K; Suzuki S; Naito S; Yamada Y; Haruki S; Kubota M; Nakajima Y; Shimizu T; Ando K; Uchida Y; Hirasawa T; Fujisaki J; Tsuchida T
Gastrointest Endosc; 2019 Jun; 89(6):1152-1159.e1. PubMed ID: 30825537
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori Eradication on the Prevention of Metachronous Lesions after Endoscopic Resection of Gastric Neoplasm: A Meta-Analysis.
Jung DH; Kim JH; Chung HS; Park JC; Shin SK; Lee SK; Lee YC
PLoS One; 2015; 10(4):e0124725. PubMed ID: 25915048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]